Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT036 in Advanced Malignant Solid Tumors
NCT07844447Phase 2Not yet recruiting
- Sponsor
- Shanghai Ruotuo Biotechnology
- Start
- Oct 2026
- Primary completion
- Oct 2029
01
Overview
A Phase 2 trial of RT036 in advanced malignant solid tumor, sponsored by Shanghai Ruotuo Biotechnology. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
RT036
03
Conditions
advanced malignant solid tumor
Beyond the preview
Go deeper on NCT07844447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07844447.